Cargando…
Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients
BACKGROUND: Genomic rearrangement in anaplastic lymphoma kinase (ALK) gene occurs in 3−7% of patients with non-small-cell lung cancer (NSCLC). The detection of this alteration is crucial as ALK positive NSCLC patients benefit from ALK inhibitors, which improve both the patient's quality of life...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
De Gruyter
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197761/ https://www.ncbi.nlm.nih.gov/pubmed/37362555 http://dx.doi.org/10.1515/almed-2019-0019 |